ArticleBMC cancer2025

Peripheral blood inflammatory biomarkers neutrophil/ lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index/albumin ratio predict prognosis and efficacy in non-small cell lung cancer patients receiving immunotherapy and opioids.

Yan Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.